Kathryn Dovel1, Frackson Shaba2, O Agatha Offorjebe3, Kelvin Balakasi2, Mike Nyirenda2, Khumbo Phiri2, Sundeep K Gupta4, Vincent Wong5, Chi-Hong Tseng6, Brooke E Nichols7, Refiloe Cele8, Eric Lungu2, Tobias Masina9, Thomas J Coates4, Risa M Hoffman4. 1. Division of Infectious Diseases, University of California Los Angeles, Los Angeles, CA, USA; Partners in Hope, Lilongwe, Malawi. Electronic address: kdovel@mednet.ucla.edu. 2. Partners in Hope, Lilongwe, Malawi. 3. Department of Medicine and David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA; School of Medicine, Charles R Drew University of Medicine and Science, Los Angeles, CA, USA. 4. Division of Infectious Diseases, University of California Los Angeles, Los Angeles, CA, USA. 5. USAID Global Health Bureau, Washington, DC, USA. 6. Division of General Internal Medicine and Health Services Research, University of California Los Angeles, Los Angeles, CA, USA. 7. Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Global Health, School of Public Health, Boston University, Boston, MA, USA. 8. Health Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. 9. Malawi Ministry of Health, HIV/AIDS Unit, Lilongwe, Malawi.
Abstract
BACKGROUND: HIV self-testing increases testing uptake in sub-Saharan Africa but scale-up is challenging because of resource constraints. We evaluated an HIV self-testing intervention integrated into high-burden outpatient departments in Malawi. METHODS: In this cluster-randomised trial, we recruited participants aged 15 years or older from 15 outpatient departments at high-burden health facilities (including health centres, mission hospitals, and district hospitals) in central and southern Malawi. The trial was clustered at the health facility level. We used constrained randomisation to allocate each cluster (1:1:1) to one of the following groups: standard provider-initiated testing and counselling with no intervention (provider offered during consultations), optimised provider-initiated testing and counselling (with additional provider training and morning HIV testing), and facility-based HIV self-testing (Oraquick HIV self-test, group demonstration and distribution, and private spaces for interpretation and counselling). The primary outcome was the proportion of outpatients tested for HIV on the day of enrolment, measured through exit surveys with a sample of outpatients. Analyses were on an intention-to-treat basis. The trial is registered with ClinicalTrials.gov, NCT03271307, and Pan African Clinical Trials, PACTR201711002697316. FINDINGS:Between Sept 12, 2017, and Feb 23, 2018, 5885 outpatients completed an exit survey-2097 in the HIV self-testing group, 1951 in the standard provider-initiated testing and counselling group, and 1837 in the optimised provider-initiated testing and counselling group. 1063 (51%) of 2097 patients in the HIV self-testing group had HIV testing on the same day as enrolment, compared with 248 (13%) of 1951 in the standard provider-initiated testing and counselling group and 261 (14%) of 1837 in the optimised provider-initiated testing and counselling group. The odds of same-day HIV testing were significantly higher in the facility-based HIV self-testing group compared with either standard provider-initiated testing and counselling (adjusted odds ratio 8·52, 95% CI 3·98-18·24) or optimised provider-initiated testing and counselling (6·29, 2·96-13·38). Around 4% of those tested in the standard provider-initiated testing and counselling and optimised provider-initiated testing and counselling groups felt coerced to test, and around 1% felt coerced to share test results. No coercion was reported in the facility-based HIV self-testing group. INTERPRETATION:Facility-based HIV self-testing increased HIV testing among outpatients in Malawi, with a minimal risk of adverse events. Facility-based HIV self-testing should be considered for scale-up in settings with a high unmet need for HIV testing. FUNDING: United States Agency for International Development.
RCT Entities:
BACKGROUND: HIV self-testing increases testing uptake in sub-Saharan Africa but scale-up is challenging because of resource constraints. We evaluated an HIV self-testing intervention integrated into high-burden outpatient departments in Malawi. METHODS: In this cluster-randomised trial, we recruited participants aged 15 years or older from 15 outpatient departments at high-burden health facilities (including health centres, mission hospitals, and district hospitals) in central and southern Malawi. The trial was clustered at the health facility level. We used constrained randomisation to allocate each cluster (1:1:1) to one of the following groups: standard provider-initiated testing and counselling with no intervention (provider offered during consultations), optimised provider-initiated testing and counselling (with additional provider training and morning HIV testing), and facility-based HIV self-testing (Oraquick HIV self-test, group demonstration and distribution, and private spaces for interpretation and counselling). The primary outcome was the proportion of outpatients tested for HIV on the day of enrolment, measured through exit surveys with a sample of outpatients. Analyses were on an intention-to-treat basis. The trial is registered with ClinicalTrials.gov, NCT03271307, and Pan African Clinical Trials, PACTR201711002697316. FINDINGS: Between Sept 12, 2017, and Feb 23, 2018, 5885 outpatients completed an exit survey-2097 in the HIV self-testing group, 1951 in the standard provider-initiated testing and counselling group, and 1837 in the optimised provider-initiated testing and counselling group. 1063 (51%) of 2097 patients in the HIV self-testing group had HIV testing on the same day as enrolment, compared with 248 (13%) of 1951 in the standard provider-initiated testing and counselling group and 261 (14%) of 1837 in the optimised provider-initiated testing and counselling group. The odds of same-day HIV testing were significantly higher in the facility-based HIV self-testing group compared with either standard provider-initiated testing and counselling (adjusted odds ratio 8·52, 95% CI 3·98-18·24) or optimised provider-initiated testing and counselling (6·29, 2·96-13·38). Around 4% of those tested in the standard provider-initiated testing and counselling and optimised provider-initiated testing and counselling groups felt coerced to test, and around 1% felt coerced to share test results. No coercion was reported in the facility-based HIV self-testing group. INTERPRETATION: Facility-based HIV self-testing increased HIV testing among outpatients in Malawi, with a minimal risk of adverse events. Facility-based HIV self-testing should be considered for scale-up in settings with a high unmet need for HIV testing. FUNDING: United States Agency for International Development.
Authors: Nolundi T Mshweshwe-Pakela; Tonderai Mabuto; Luke Shankland; Alex Fischer; Dikeledi Tsukudu; Christopher J Hoffmann Journal: South Afr J HIV Med Date: 2022-06-13 Impact factor: 1.835
Authors: Juliet Iwelunmor; Joseph D Tucker; Chisom Obiezu-Umeh; Titilola Gbaja-Biamila; David Oladele; Ucheoma Nwaozuru; Adesola Z Musa; Collins O Airhihenbuwa; Kathryn Muessig; Nora Rosenberg; Rhonda BeLue; Hong Xian; Donaldson F Conserve; Jason J Ong; Lei Zhang; Jamie Curley; Susan Nkengasong; Stacey Mason; Weiming Tang; Barry Bayus; Gbenga Ogedegbe; Oliver Ezechi Journal: Contemp Clin Trials Date: 2021-11-17 Impact factor: 2.261
Authors: Jillian Neary; Michelle A Bulterys; Emily A Ogutu; Gabrielle O'Malley; Anita A Otieno; Vincent O Omondi; Yu Wang; Xinyi Zhai; David A Katz; Laura Oyiengo; Dalton C Wamalwa; Jennifer A Slyker; Grace C John-Stewart; Irene N Njuguna; Anjuli D Wagner Journal: J Acquir Immune Defic Syndr Date: 2022-08-15 Impact factor: 3.771
Authors: Cheryl Johnson; Melissa Neuman; Peter MacPherson; Augustine Choko; Caitlin Quinn; Vincent J Wong; Karin Hatzold; Rose Nyrienda; Getrude Ncube; Rachel Baggaley; Fern Terris-Prestholt; Elizabeth L Corbett Journal: BMC Public Health Date: 2020-05-25 Impact factor: 3.295
Authors: Valentine Wanga; Victor Omollo; Elizabeth A Bukusi; Josephine B Odoyo; Jennifer F Morton; Lara Kidoguchi; Rachel Johnson; James P Hughes; Connie Celum; Jared M Baeten Journal: J Int AIDS Soc Date: 2020-08 Impact factor: 5.396
Authors: Nonzuzo Mbokazi; Rutendo Madzima; Natalie Leon; Mark N Lurie; Morna Cornell; Bey-Marrie Schmidt; Christopher J Colvin Journal: J Int Assoc Provid AIDS Care Date: 2020 Jan-Dec
Authors: Augustine T Choko; Katherine Fielding; Cheryl C Johnson; Moses K Kumwenda; Richard Chilongosi; Rachel C Baggaley; Rose Nyirenda; Linda A Sande; Nicola Desmond; Karin Hatzold; Melissa Neuman; Elizabeth L Corbett Journal: Lancet Glob Health Date: 2021-07 Impact factor: 26.763
Authors: Anna Grimsrud; Lynne Wilkinson; Ingrid Eshun-Wilson; Charles Holmes; Izukanji Sikazwe; Ingrid T Katz Journal: Curr HIV/AIDS Rep Date: 2020-10 Impact factor: 5.071
Authors: Pitchaya P Indravudh; Katherine Fielding; Richard Chilongosi; Rebecca Nzawa; Melissa Neuman; Moses K Kumwenda; Rose Nyirenda; Cheryl C Johnson; Miriam Taegtmeyer; Nicola Desmond; Karin Hatzold; Elizabeth L Corbett Journal: BMJ Glob Health Date: 2021-07